Vanda Pharmaceuticals (VNDA) Return on Capital Employed [ROCE] (2011 - 2026)
Vanda Pharmaceuticals' Return on Capital Employed [ROCE] was -71.70% in Q2 2026, down 51.81 percentage points from -19.89% a year earlier and down 22.45 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Vanda Pharmaceuticals came in at -35.37%, down 28.01 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for four consecutive years, with a five-year change of -41.52 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -7.36% in FY2024 (-4.84 pp), -2.52% in FY2023 (-3.73 pp), 1.21% in FY2022 (-7.41 pp) and 8.62% in FY2021 (+2.47 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q3 2014.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 18 straight quarters, with an average year-over-year change of -21.29 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 4.09 percentage points); the worst was Q2 2026 (a drop of 51.81 percentage points).
- Per Business Quant data, VNDA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -49.24% (Q1 2026), -37.80% (Q4 2025) and -24.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | -71.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -71.70% |
| Mar 31, 2026 | -49.24% |
| Dec 31, 2025 | -37.80% |
| Sep 30, 2025 | -24.46% |
| Jun 30, 2025 | -19.89% |
| Mar 31, 2025 | -13.41% |
| Dec 31, 2024 | -7.38% |
| Sep 30, 2024 | -6.70% |
| Jun 30, 2024 | -5.82% |
| Mar 31, 2024 | -4.52% |
| Dec 31, 2023 | -2.50% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | 1.74% |
| Mar 31, 2023 | 2.93% |
| Dec 31, 2022 | 1.18% |
| Sep 30, 2022 | 1.59% |
| Jun 30, 2022 | 2.94% |
| Mar 31, 2022 | 4.76% |
| Dec 31, 2021 | 8.23% |
| Sep 30, 2021 | 8.77% |
API Access
Vanda Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();